01662cam a2200325 a 45000010008000000030008000080050017000160080041000330100017000740200022000910200022001130400036001350820018001712450188001892600060003773000027004375000170004645040051006345050210006856500042008956500061009376500060009986500037010586500042010956500030011377000022011677000024011897100085012137100038012984360012BD-DhUL20170420143445.0900723m19901992dcua     b    001 0 eng c  a   90006633   a0309042852 (v. 1)  a0309043964 (v. 2)  aDNLM/DLCcBD-DhULdDLCdBD-DhUL  a362.2909bTRE00aTreating drug problems /cCommittee for the Substance Abuse Coverage Study, Division of Health Care Services, Institute of Medicine ; Dean R. Gerstein and Henrick J. Harwood, editors.  aWashington, D.C. :bNational Academy Press,c1990-1992.  a2 v. :bill. ;c24 cm.  a"This study was supported by the National Institute on Drug Abuse, U.S. Department of Health and Human Services, under Contract No. 283-88-0009 (SA)/9D/--T.p. verso.  aIncludes bibliographical references and index.1 av. 1. A study of the evolution, effectiveness, and financing of public and private drug treatment systems -- v. 2. Commissioned papers on historical, institutional, and economic contexts of drug treatment. 0aDrug abusexTreatmentzUnited States. 0aDrug abusexTreatmentxGovernment policyzUnited States. 0aDrug abusexTreatmentxEconomic aspectszUnited States. 0aHealth insurancezUnited States. 2aFinancing, GovernmentzUnited States. 2aSubstance Abusextherapy.1 aGerstein, Dean R.1 aHarwood, Henrick J.2 aInstitute of Medicine (U.S.).bCommittee for the Substance Abuse Coverage Study.2 aNational Institute on Drug Abuse.